论文部分内容阅读
由L8（27）表按排治疗3月龄以下伴有憋气的百日咳及百日咳综合征80例。观察憋气Apgar评分减轻1度的天数和憋气消失无数，以比较应用地塞米松、息斯敏、20％人体白蛋白和维生素K1用与不用对上述两者的影响。经方差分析结果，前者依次为P＜0．01;P＞0.05；P＜0.05和P＞0．05；后者依次为P＜0．01；P＞0．05；P＞0．05和P＞0．05。极差分析，前者地塞米松为1.1625天、20％人体白蛋白为0.8125天，后者地塞米松为1．175天。结果提示，地塞米松能较快地减轻憋气的严重程度，并能缩短憋气的发作天数；20％人体白蛋白也能减轻憋气的严重程度，但作用比地塞米松差。
Table L8 (27) by the row of treatment for 3 months of age with breathless pertussis and pertussis syndrome 80 cases. Observe the suffocating Apgar score to reduce the number of days 1 and suffocation disappeared countless to compare the application of dexamethasone, astemizole, 20% human albumin and vitamin K1 with and without the impact of both. The results of analysis of variance showed that the former were P <0.01; P> 0.05; P <0.05 and P> 0.05; the latter were P <0.01; P> 0.05; P> 0.05 P> 0.05. Analysis of the difference, the former dexamethasone is 1.1625 days, 20% human albumin is 0.8125 days, the latter is dexamethasone is 1.175 days. The results suggest that dexamethasone can quickly reduce the severity of suffocation and shorten the episode of suffocation; 20% human albumin can also reduce the severity of suffocation, but the effect is worse than dexamethasone.